Furthermore, higher OTUD1 expression was significantly associated with low recurrence-free survival of HER2+ non-luminal subtype of breast cancer patients and EMT subtype of cervical cancer patients (Fig. 6c, d). This evidence concerns the gene ERBB2 and breast cancer.